Skip to main content
. 2013 Aug;103(8):e34–e43. doi: 10.2105/AJPH.2013.301394

TABLE 1—

Baseline Characteristics of Participants: Women’s Health Initiative (WHI), United States, 1993–2005

Variable Weight Analyses (n = 71 809), No. (%) or Mean ±SD Metabolic Measure Analyses (n = 2242), No. (%) or Mean ±SD Inflammatory Marker Analyses (n = 1950), No. (%) or Mean ±SD
Age at screening, y 63.5 ±7.28 62.3 ±6.93 62.0 ±6.84
Race/ethnicity
 American Indian or Alaskan Native 242 (0.3) 0 (0) 39 (2.0)
 Asian or Pacific Islander 2112 (3.0) 173 (7.7) 174 (8.9)
 Black 4624 (6.5) 663 (29.6) 430 (22.1)
 Hispanic or Latino 2172 (3.0) 260 (11.6) 220 (11.3)
 White 61 725 (86.2) 1145 (51.1) 1042 (53.4)
 Other 755 (1.0) 1 (< 0.1) 45 (2.3)
Education
 < high school 2802 (3.9) 196 (8.8) 131 (6.7)
 High school or GED 11 102 (15.6) 355 (16.0) 381 (19.6)
 > high school, < 4 y college 25 657 (36.0) 845 (38.1) 729 (37.5)
 ≥ 4 y college 31 705 (44.5) 821 (37.0) 705 (36.2)
Smoking status
 Never 36 611 (51.6) 1196 (54.1) 1040 (54.1)
 Former 30 433 (42.9) 878 (39.7) 739 (38.4)
 Current 3950 (5.6) 137 (6.2) 144 (7.5)
Hormone therapy use
 Never used hormones 20 275 (28.8) 779 (35.5) 831 (44.0)
 Past hormone user 14 511 (20.6) 459 (20.9) 554 (29.4)
 Current hormone user 35 721 (50.7) 957 (43.6) 502 (26.6)
Family history of diabetes
 Yes 21 520 (31.4) 942 (44.9) 711 (38.7)
 No 47 068 (68.6) 1155 (55.1) 1128 (61.3)
Elevated depressive symptoms at baseline
 Yes 10 474 (14.6) 357 (15.9) 263 (13.5)
 No 61 335 (85.4) 1885 (84.1) 1687 (86.5)
Taking antidepressant medication at baseline
 Yes 5061 (7.0) 144 (6.42) 67 (3.4)
 No 66 748 (93.0) 2098 (93.6) 1883 (96.6)
Taking antidepressant medication and having elevated depressive symptoms at baseline
 Not depressed, not taking antidepressant medication 57 713 (80.4) 1790 (79.8) 1642 (84.2)
 Not depressed, taking antidepressant medication 3622 (5.0) 95 (4.2) 45 (2.3)
 Depressed, not taking antidepressant medication 9035 (12.6) 308 (13.7) 241 (12.4)
 Depressed, taking antidepressant medication 1439 (2.0) 49 (2.2) 22 (1.1)
WHI participation condition
 Observation study 71 809 (100.0) 2242 (100.0) 1950 (100)
 Estrogen-alone trial only 284 (14.6)
 Estrogen plus progestin trial only 453 (23.2)
 Dietary modification trial only 797 (40.9)
 HRT and dietary trials 416 (21.3)

Note. GED = general equivalency diploma; HRT = hormone replacement therapy.